MCK Q2 2023 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q2 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$70.2B+5.4% YoY

Gross Profit

$3.0B4.3% margin

Operating Income

$1.1B1.6% margin

Net Income

$926M1.3% margin

EPS (Diluted)

$6.43

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$1.1B

Free Cash Flow

$985M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$63.1B

Total Liabilities

$64.3B

Stockholders' Equity

-$1.8B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70.2B	$66.6B	+5.4%
Gross Profit	$3.0B	$3.2B	-6.8%
Operating Income	$1.1B	$683M	+67.6%
Net Income	$926M	$267M	+246.8%

Revenue Segments

U.S. Pharmaceutical Segment

$60.1B86%

International Segment

$6.2B9%

Medical-Surgical Solutions Segment

$2.8B4%

Prescription Technology Solutions

$1.0B1%